Sanofi (SNY)
NASDAQ: SNY · IEX Real-Time Price · USD
49.39
+0.16 (0.33%)
May 1, 2024, 10:55 AM EDT - Market open
Sanofi Employees
Sanofi had 86,088 employees on December 31, 2023. The number of employees decreased by 5,485 or -5.99% compared to the previous year.
Employees
86,088
Change (1Y)
-5,485
Growth (1Y)
-5.99%
Revenue / Employee
$599,438
Profits / Employee
$69,696
Market Cap
116.88B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
Dec 31, 2020 | 99,412 | -997 | -0.99% |
Dec 31, 2019 | 100,409 | -3,817 | -3.66% |
Dec 31, 2018 | 104,226 | -2,340 | -2.20% |
Dec 31, 2017 | 106,566 | -293 | -0.27% |
Dec 31, 2016 | 106,859 | -2,230 | -2.04% |
Dec 31, 2015 | 109,089 | 1,702 | 1.58% |
Dec 31, 2014 | 107,387 | -4,741 | -4.23% |
Dec 31, 2013 | 112,128 | 154 | 0.14% |
Dec 31, 2012 | 111,974 | -1,745 | -1.53% |
Dec 31, 2011 | 113,719 | 12,144 | 11.96% |
Dec 31, 2010 | 101,575 | -3,292 | -3.14% |
Dec 31, 2009 | 104,867 | 6,654 | 6.78% |
Dec 31, 2008 | 98,213 | -1,282 | -1.29% |
Dec 31, 2007 | 99,495 | -794 | -0.79% |
Dec 31, 2006 | 100,289 | 3,108 | 3.20% |
Dec 31, 2005 | 97,181 | 742 | 0.77% |
Dec 31, 2004 | 96,439 | 63,353 | 191.48% |
Dec 31, 2003 | 33,086 | 650 | 2.00% |
Dec 31, 2002 | 32,436 | 1,922 | 6.30% |
Dec 31, 2001 | 30,514 | 1,314 | 4.50% |
Dec 31, 2000 | 29,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Elevance Health | 104,900 |
Medtronic | 95,000 |
Pfizer | 88,000 |
Cigna | 72,500 |
Boston Scientific | 48,000 |
Amgen | 26,700 |
Stryker | 26,700 |
Intuitive Surgical | 13,676 |
SNY News
- 23 hours ago - Press Release: Annual General Meeting of April 30, 2024 - GlobeNewsWire
- 6 days ago - Sanofi Sales, Profit Beat Forecasts - WSJ
- 6 days ago - Sanofi Q1 profit slips on generic competition, forex effects - Reuters
- 6 days ago - Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance - GlobeNewsWire
- 7 days ago - FTC looking to accelerate inquiry into prescription-drug middlemen, chair says - Market Watch
- 8 days ago - Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia - GlobeNewsWire
- 12 days ago - Sanofi to overhaul US operations of vaccines, cut jobs - Reuters
- 14 days ago - COTA Announces Strategic Collaboration with Sanofi to Leverage Real-World Data and AI to Accelerate Cancer Trials - Business Wire